DAMORA THERAPEUTICS, INC. (DMRA) Free cash flow 2022–2023
DAMORA THERAPEUTICS, INC. (DMRA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$37.1MFY2023 · since FY2022: -$43.2M → -$37.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -$37.1M | +14.0% |
| FY2022 | -$43.2M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice